All information is based on sources from scientific studiesAll essential peptide information in one placeNote: NOT medical advice and not for human useAll of our protocols are free to consult
Back to learning center

PNC-27

p53-derived peptide studied in preclinical oncology research.

Disclaimer: Educational material only. Values may differ by product type (pen vs vial). Do your own research, at your own risk, for informational purposes only. Not for human consumption. Consult a qualified healthcare professional before making any decision about this compound.

About this peptide

PNC-27 is a synthetic peptide combining a p53 binding domain with a penetratin-like membrane residue. It has only been studied in laboratory and animal research.

How it works

Cell studies describe binding to HDM-2 in the membrane of certain tumour cells, forming pores that cause necrosis of those cells without affecting healthy cells.

Storage instructions

Store the sealed lyophilized vial at 2-8 °C, protected from light; brief exposure to room temperature during shipping is generally tolerated. Refrigerate after reconstitution at 2-8 °C and use within the period supported by stability data for the substance (typically 2-4 weeks). Avoid repeated freeze-thaw cycles: each cycle increases the risk of aggregation and hydrolysis of the peptide bond. Do not shake the vial; swirl gently and direct the liquid stream against the glass wall rather than at the powder cake.

Required supplies

  • Sealed lyophilized vial, stored as supplied
  • Bacteriostatic water (0.9% benzyl alcohol) for reconstitution
  • Insulin syringes (29-31G, 0.5 mL / 100 units)
  • Reconstitution syringe (1-3 mL, 21-23G needle)
  • 70% isopropyl alcohol swabs
  • Sharps container for used needles
  • Labels and a logbook for batch, date and volume

Possible effects & side effects

There are no human clinical studies. All reported effects come from in vitro and rodent models; clinical relevance is unknown.

Injection technique

Wash your hands, then disinfect the vial septum and the injection site with 70% isopropyl alcohol and allow both to air dry. Draw up the intended volume, remove air bubbles and pinch a subcutaneous skin fold. Insert at a 45-90° angle depending on fat thickness, aspiration is not required for subcutaneous administration, and inject slowly. Withdraw the needle, apply light pressure and discard the needle in a sharps container. Rotate injection sites systematically (abdominal quadrants, flanks, thighs) to prevent lipohypertrophy and local irritation.

Lifestyle factors

Peptide research protocols are studied against a background of adequate protein intake (approximately 1.6-2.2 g/kg/day in the training literature), consistent sleep of 7-9 hours, and controlled training load. Sleep deprivation and chronic psychological stress both dampen growth hormone pulsatility and disrupt tissue remodeling, complicating the interpretation of any observed effect. Alcohol, smoking and large caloric deficits are likewise documented modifiers of recovery outcomes.

References

  1. Michl J. et al. PNC-27 anticancer peptide induces membranolysis of cancer cells. Ann N Y Acad Sci, 2006.
  2. Sarafraz-Yazdi E. et al. Anticancer peptide PNC-27 adopts a HDM-2-binding conformation. PNAS, 2010.